Literature DB >> 12736165

Diabetic kidney disease in the db/db mouse.

Kumar Sharma1, Peter McCue, Stephen R Dunn.   

Abstract

Diabetic nephropathy is increasing in incidence and is now the number one cause of end-stage renal disease in the industrialized world. To gain insight into the genetic susceptibility and pathophysiology of diabetic nephropathy, an appropriate mouse model of diabetic nephropathy would be critical. A large number of mouse models of diabetes have been identified and their kidney disease characterized to various degrees. Perhaps the best characterized and most intensively investigated model is the db/db mouse. Because this model appears to exhibit the most consistent and robust increase in albuminuria and mesangial matrix expansion, it has been used as a model of progressive diabetic renal disease. In this review, we present the findings from various studies on the renal pathology of the db/db mouse model of diabetes in the context of human diabetic nephropathy. Furthermore, we discuss shortfalls of assessing functional renal disease in mouse models of diabetic kidney disease.

Entities:  

Mesh:

Year:  2003        PMID: 12736165     DOI: 10.1152/ajprenal.00315.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  161 in total

1.  Environmental tobacco smoke furthers progression of diabetic nephropathy.

Authors:  David M Obert; Ping Hua; Meagan E Pilkerton; Wenguang Feng; Edgar A Jaimes
Journal:  Am J Med Sci       Date:  2011-02       Impact factor: 2.378

Review 2.  Sodium-glucose transport: role in diabetes mellitus and potential clinical implications.

Authors:  Volker Vallon; Kumar Sharma
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-09       Impact factor: 2.894

Review 3.  Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.

Authors:  Jun Oh; Jochen Reiser; Peter Mundel
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

4.  A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8.

Authors:  Streamson Chua; Yifu Li; Shun Mei Liu; Ruijie Liu; Ka Tak Chan; Jeremiah Martino; Zongyu Zheng; Katalin Susztak; Vivette D D'Agati; Ali G Gharavi
Journal:  Kidney Int       Date:  2010-06-02       Impact factor: 10.612

5.  Renal and glycemic effects of high-dose chromium picolinate in db/db mice: assessment of DNA damage.

Authors:  Mahmood S Mozaffari; Babak Baban; Rafik Abdelsayed; Jun Yao Liu; Hereward Wimborne; Nancy Rodriguez; Worku Abebe
Journal:  J Nutr Biochem       Date:  2011-09-29       Impact factor: 6.048

6.  Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy.

Authors:  Julia M Hum; Linda M O'Bryan; Arun K Tatiparthi; Erica L Clinkenbeard; Pu Ni; Martin S Cramer; Manoj Bhaskaran; Robert L Johnson; Jonathan M Wilson; Rosamund C Smith; Kenneth E White
Journal:  J Appl Physiol (1985)       Date:  2019-01-03

7.  Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin.

Authors:  Kavithalakshmi Sataranatarajan; Meenalakshmi M Mariappan; Myung Ja Lee; Denis Feliers; Goutam Ghosh Choudhury; Jeffrey L Barnes; Balakuntalam S Kasinath
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

8.  KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria.

Authors:  Kaori Hayashi; Hiroyuki Sasamura; Mari Nakamura; Tatsuhiko Azegami; Hideyo Oguchi; Yusuke Sakamaki; Hiroshi Itoh
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

9.  Pharmacological properties of ASP7657, a novel, potent, and selective prostaglandin EP4 receptor antagonist.

Authors:  Kazuhiko Mizukami; Hiroaki Kamada; Hiroyuki Yoshida; Ikuko Ishii; Eisuke Nozawa; Koichi Wada; Tohru Ugawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-03       Impact factor: 3.000

10.  Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.

Authors:  Kelli M Sas; Pradeep Kayampilly; Jaeman Byun; Viji Nair; Lucy M Hinder; Junguk Hur; Hongyu Zhang; Chengmao Lin; Nathan R Qi; George Michailidis; Per-Henrik Groop; Robert G Nelson; Manjula Darshi; Kumar Sharma; Jeffrey R Schelling; John R Sedor; Rodica Pop-Busui; Joel M Weinberg; Scott A Soleimanpour; Steven F Abcouwer; Thomas W Gardner; Charles F Burant; Eva L Feldman; Matthias Kretzler; Frank C Brosius; Subramaniam Pennathur
Journal:  JCI Insight       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.